SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001072613-17-000110
Filing Date
2017-02-13
Accepted
2017-02-13 15:28:03
Documents
1
Group Members
COREY GOODMANROBERT ADELMANVENBIO GLOBAL STRATEGIC GP II, L.P.VENBIO GLOBAL STRATEGIC GP II, LTD.

Document Format Files

Seq Description Document Type Size
1 NABRIVA THERAPEUTICS AG - SCHEDULE 13GA (AMEND. #1) sch13g_18038.htm SC 13G/A 172120
  Complete submission text file 0001072613-17-000110.txt   173766
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund II L.P. (Filed by) CIK: 0001634632 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89113 | Film No.: 17598676
SIC: 2834 Pharmaceutical Preparations